These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31062197)

  • 1. Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5.
    Tanemoto M
    Clin Exp Nephrol; 2019 Aug; 23(8):1045-1049. PubMed ID: 31062197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease.
    Tanemoto M; Kamachi R; Kimura T; Yamada S; Yokoyama T; Okazaki Y
    Clin Exp Nephrol; 2020 Dec; 24(12):1140-1143. PubMed ID: 32772208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin associated lactic acidosis (MALA): clinical profiling and management.
    Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
    J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid retention in chronic kidney disease is inversely related to GFR.
    Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
    Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
    Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
    Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Acidosis of CKD: An Update.
    Kraut JA; Madias NE
    Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Metabolic Acidosis in Chronic Kidney Disease.
    Tanemoto M
    Kidney Dis (Basel); 2020 Jan; 6(1):59-63. PubMed ID: 32021875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis.
    Forni LG; McKinnon W; Lord GA; Treacher DF; Peron JM; Hilton PJ
    Crit Care; 2005 Oct; 9(5):R591-5. PubMed ID: 16277723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
    Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
    Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant?
    Prabhu RA; Mareddy AS; Nagaraju SP; Rangaswamy D; Guddattu V
    Int Urol Nephrol; 2019 Jul; 51(7):1229-1230. PubMed ID: 30963454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
    Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anion gap in the differential diagnosis of metabolic acidosis in critically ill newborns.
    Lorenz JM; Kleinman LI; Markarian K; Oliver M; Fernandez J
    J Pediatr; 1999 Dec; 135(6):751-5. PubMed ID: 10586180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.
    Trimarchi H; Muryan A; Martino D; Toscano A; Iriarte R; Campolo-Girard V; Forrester M; Pomeranz V; Fitzsimons C; Lombi F; Young P; Raña MS; Alonso M
    J Nephrol; 2012; 25(6):1003-15. PubMed ID: 22322818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
    Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study.
    Noritomi DT; Soriano FG; Kellum JA; Cappi SB; Biselli PJ; Libório AB; Park M
    Crit Care Med; 2009 Oct; 37(10):2733-9. PubMed ID: 19885998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study.
    Nakano T; Tanaka S; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2021 Apr; 25(4):385-393. PubMed ID: 33398604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.